Actinium Pharmaceuticals, Inc. (Delaware) (ATNM): Price and Financial Metrics
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
Today's Latest Price: $0.23 USD
0.01 (-4.14%)
Updated Feb 27 6:40pm
Add ATNM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ATNM Daily Price Range
ATNM 52-Week Price Range
ATNM Stock Price Chart More Charts
ATNM Price/Volume Stats
| Current price | $0.23 | 52-week high | $0.65 |
| Prev. close | $0.24 | 52-week low | $0.19 |
| Day low | $0.22 | Volume | 1,425,900 |
| Day high | $0.23 | Avg. volume | 2,934,736 |
| 50-day MA | $0.24 | Dividend yield | N/A |
| 200-day MA | $0.24 | Market Cap | 37.76M |
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Company Bio
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The companys targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The company was founded in 2000 and is based in New York City, New York.
Top Stories View All
CGC SNDL IIPR GWPH TLRY Cannabis Stocks: The Week in Review
Best & Worst Performing Stock Industries for February 27, 2020
Best & Worst Performing Small Cap Stocks for February 27, 2020
Best & Worst Performing Mid Cap Stocks for February 27, 2020
Best & Worst Performing Large Cap Stocks for February 27, 2020
View All Top Stories
Loading social stream, please wait...